Canada · Delayed Price · Currency is CAD Ayr Wellness Earnings Call Transcripts
Fiscal Year 2024
-
Q4 sales were flat at $114M, with gross profit and EBITDA pressured by price compression and inventory challenges. Strategic focus is on core markets, operational streamlining, and launching a new Florida facility to drive growth, while leadership transitions and asset divestitures continue.
-
Q3 revenue declined 2.5% sequentially and was flat year-over-year, with adjusted EBITDA margin improving to 22.9%. Expansion in Ohio and Florida continues, while cost-saving initiatives and leadership changes aim to drive efficiency and future growth.
-
Q2 2024 revenue was flat at $117.3M, with adjusted EBITDA margin down to 21.9% due to price compression and operational investments. Growth is expected in H2 2024 from Ohio adult-use sales, new store openings, and margin recovery, with positive cash flow and free cash flow targeted for the year.